WarfarinDate of publication:…
WarfarinDate of publication: 08/08/2025
Piperacillin/tazobactamDate of…
Piperacillin/tazobactamDate of publication: 08/08/2025
LoperamideDate of publication:…
LoperamideDate of publication: 08/08/2025
LinezolidDate of publication:…
LinezolidDate of publication: 08/08/2025
LevosimendanDate of publication:…
LevosimendanDate of publication: 08/08/2025
LactuloseDate of publication:…
LactuloseDate of publication: 08/08/2025
GliclazideDate of publication:…
GliclazideDate of publication: 08/08/2025
ICH E2B(R3) Q&As, Implementation Guide, and Appendix I (G) Reach Step 4 of the ICH Process
The ICH Secretariat is pleased to announce that the updated ICH E2B(R3) Q&As, the Implementation Guide, and Appendix I (G) for the ICH E2B(R3) Guideline: Electronic Transmission of Individual Case Safety Reports (ICSRs) have reached Step 4 of the ICH Process.
Repevax, Adacel-Polio,…
Repevax, Adacel-Polio, Triaxis-Polio (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine (Tdap-IPV))End of procedure: 21/05/2025Date of publication: 01/08/2025
Instructions for RMS when…
Instructions for RMS when preparing the PAR based on the FAR (July 2025)PAR template (empty) - when prepared based on FAR (July 2025)